Cytidine Analog RX-3117

An orally available small molecule and nucleoside antimetabolite with potential antineoplastic activity. Upon administration, the cytidine analog RX-3117 is taken up by cells through a carrier-mediated transporter, phosphorylated by uridine cytidine kinase (UCK) and then further phosphorylated to its diphosphate (RX-DP) and triphosphate forms (RX-TP). The triphosphate form is incorporated into RNA and inhibits RNA synthesis. The diphosphate RX-DP is reduced by ribonucleotide reductase (RR) to dRX-DP; its triphosphate form (dRX-TP) is incorporated into DNA. In addition, RX-3117 also inhibits DNA methyltransferase 1 (DNMT1). This eventually leads to cell cycle arrest and the induction of apoptosis. UCK is the rate-limiting enzyme in the pyrimidine-nucleotide salvage pathway. (NCI Thesaurus)

YOU MAY ALSO LIKE

Cytidine

A pyrimidine nucleoside that is composed of the base cytosine linked to the five-carbon sugar D-ribose.

Cytembena

A cytostatic agent that interferes with DNA synthesis.

Cytarabine-Thioguanine Regimen

A regimen consisting of cytarabine and thioguanine used as post remission maintenance treatment for acute myeloid leukemia. Was originally used as an…

Cytarabine-Mitoxantrone Regimen

A regimen consisting of cytarabine and mitoxantrone used as both induction and consolidation (post remission) treatment for acute myeloid leukemia. This regimen…

Cytarabine-Idarubicin Regimen

A regimen consisting of cytarabine and idarubicin used as both an induction and consolidation (post remission) treatment for acute myeloid leukemia. …

Cytarabine-Daunorubicin-Etoposide Regimen

A regimen consisting of cytarabine, daunorubicn, and etoposide used as an induction regimen for the treatment of acute myeloid leukemia.